Esin Şener
Ankara University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Esin Şener.
European Journal of Pharmaceutical Sciences | 1999
İlkay Ören; Özlem Temiz; Ismail Yalcin; Esin Şener; Nurten Altanlar
A new series of 2,5- and/or 6-substituted benzoxazoles (7a-f), benzimidazoles (8a-g) holding cyclohexyl or cyclopentyl moieties at position 2 and 5- or 6-substituted-2-cyclohexylaminomethylbenzoxazoles (9a, b) was synthesized in order to determine their antimicrobial activities and feasible structure-activity relationships. The synthesized compounds were tested in vitro against three Gram-positive, two Gram-negative bacteria and the yeast Candida albicans in comparison with several control drugs. Microbiological results showed that the synthesized compounds were possessing a broad spectrum of antibacterial activity against the tested microorganisms. 5-Chloro-2-(2-cyclohexylethyl)benzimidazole (8g) was found as the most active compound against the screened Gram-positive bacteria strains at a minimum inhibitory concentration (MIC) value of 12.5 microg/ml. However, it exhibited lower antibacterial potency than the compared control drugs. On the other side, compounds 7-9 indicated significant antibacterial activity against the Gram-negative enterobacter Pseudomonas aeruginosa having MIC values of 50 microg/ml, providing either the same effect as tetracycline or higher activity than streptomycin, but showing less potency than the compared control drug gentamycin. Moreover, the synthesized compounds also possessed antimycotic activity against the yeast C. albicans showing MIC values between 25-50 microg/ml.
European Journal of Medicinal Chemistry | 1992
Ismail Yalcin; İlkay Ören; Esin Şener; Ahmet Akin; Nejat Uçartürk
Abstract The synthesis of a new series of 2,5-disubstituted benzoxazoles 4a–f , 2-substituted oxazolo(4,5- b )pyridines 5a, b , benzothiazoles 6a, b and benzimidazoles 7a, b is described in order to determine their antimicrobial activities and feasible structure-activity relationships (SAR). The synthesized compounds were tested in vitro against 3 Gram-positive, 3 Gram-negative, and a fungus Candida albicans , 4b, 4e and 4f were found to be more active than the others against Klebsiella pneumoniae at a MIC value of 12.5 μg/ml. All the derivatives 4–7 exhibited significant antimycotic activity against C albicans . The antibacterial and antimycotic activities of 4–7 are also compared with several standard drugs.
Farmaco | 1998
Özlem Temiz; İlkay Ören; Esin Şener; Ismail Yalcin; Nejat Uçartürk
The synthesis of a new series of 5-or 6-methyl-2-(2,4-disubstituted phenyl) benzoxazoles (4, 5) is described in order to determine their antimicrobial activities and feasible structure-activity relationships. The synthesized compounds were tested in vitro against three Gram-positive bacteria, three Gram-negative bacteria and the yeast Candida albicans, in comparison with several control drugs. Microbiological results exhibited that the synthesized compounds possess a broad spectrum of antibacterial activity against the tested microorganisms. The compounds 4b and 4c indicated some antibacterial activity against Staphylococcus aureus having a minimum inhibitory concentration (MIC) of 12.5 micrograms/ml. Moreover, the compound 5a revealed a significant antibacterial activity against the enterobacter Pseudomonas aeruginosa showing a MIC value of 25 micrograms/ml, i.e. more potent than the control drugs tetracycline and streptomycin. For the antimycotic activity against the yeast C. albicans, the derivative 4c was found to be more active than the other synthesized compounds with a MIC value of 12.5 micrograms/ml, but one-fold less potent than the control drugs oxiconazole and haloprogin.
European Journal of Medicinal Chemistry | 1990
İsmail Yalçin; Esin Şener; T Özden; Seçkin Özden; Ahmet Akin
The synthesis and microbiological activity of a series of 5-methyl-2-(p-substituted phenyl)benzoxazoles 7a–7g are described. The in vitro microbiological activity of these compounds was determined against some Gram-positive and Gram-negative bacteria and C albicans. The observed minimum inhibitory concentration (MIC) values of the derivatives were compared to some other 2,5-disubstituted benzoxazoles and clinically used drugs. The in vitro microbiological data showed that the derivatives 7a–7g exhibited a broad spectrum of antibacterial activity and 7a–c and 7g were significantly active against E coli and/or K pneumoniae at an MIC of 6.2 μg/ml.
Farmaco | 2000
Esin Şener; Özlem Temiz Arpaci; Ismail Yalcin; Nurten Altanlar
The synthesis and microbiological activity of a new series of 5-benzamido- and 5-phenylacetamidosubstituted-2-phenylbenzoxazole derivatives (1-26) were described. The in vitro microbiological activity of the compounds was determined against Gram-positive, Gram-negative bacteria and the yeast Candida albicans in comparison with standard drugs. Microbiological results indicated that the synthesized compounds possessed a broad spectrum of activity against the tested microorganisms. The compounds 1, 21, 25 showed higher activity than tetracycline and streptomycin against Pseudomonas aeruginosa.
Farmaco | 2000
Esin Şener; Kamuran K. Bingöl; İlkay Ören; Özlem Temiz Arpaci; Ismail Yalcin; Nurten Altanlar
The synthesis of some N-(o-hydroxyphenyl)benzamides and benzacetamides (2a-2p) in order to determine their in vitro antimicrobial activity against two Gram-positive bacteria, three Gram-negative bacteria and the fungus Candida albicans is described. The new compounds were compared with several control drugs. The derivative 2g, 4-amino-N-(o-hydroxyphenyl)benzamide, was found active at an MIC value of 25 microg/ml against the Gram-negative microorganism Klebsiella pneumoniae. Most of the compounds exhibited antibacterial activity at an MIC value of 25 microg/ml against Pseudomonas aureginosa. For the antifungal activity against C. albicans, compounds 2e, 2h and 2m were found more active than the other derivatives (MIC 12.5 microg/ml). The antimicrobial activity of some of these benzamide and phenylacetamide derivatives (2a, 2b, 2f, 2g, 2h and 2k), possible metabolites of benzoxazoles, was also compared with that of the cyclic analogues 3-8. Compound 2f possesses two dilutions better antifungal activity than its cyclic analogue the benzoxazole derivative 5 against C. albicans, while having one dilution better antibacterial activity against Streptococcus faecalis and K. pneumoniae.
International Journal of Pharmaceutics | 1993
Ismail Yalcin; Esin Şener
Abstract A set of previously synthesized 2,5-disubstituted benzimidazole (I), benzoxazole (II), and 2-substituted oxazolo(4,5-b)pyridine (III) derivatives were tested for in vitro growth inhibitory activity against K. pneumoniae and the quantitative structure-activity relationships (QSARs) were analyzed by a computer-assisted multiple regression procedure. The activity contributions for either heterocyclic ring systems or substituent effects were determined from the correlation equations and predictions for the lead optimization were described. The resulting QSAR revealed that the oxazolo(4,5-b)pyridine ring system with the substitution of a benzyl moiety at position 2 was the most favorable structure over the other heterocyclic nuclei against K. pneumoniae. The position R in the fused ring system was found to be important for improving the activity by substitution at this position by hydrogen accepting groups with the electronic effect of negative field interactions.
International Journal of Pharmaceutics | 1994
Esin Şener; Hülya Turgut; Ismail Yalcin; İlkay Ören; Lemi Türker; Nihat Çelebi; Ahmet Akin
The synthesis and in vitro antimicrobial activity of 5-substituted 2-(3-pyridyl)benzoxazoles (3–7) is described for some Gram-positive and Gram-negative bacteria and the yeast Candida albicans. The compounds 3–7 exhibited significant activity against the screened microorganisms, having MIC values between 25 and 12.5 μg/ml. Quantum-chemical calculations were performed for the compounds 1–10, in order to observe some feasible structure-activity relationships. These theoretical observations, calculated for the description of the mechanism of interactions at the molecular level, revealed that the electrophilic superdelocalizability of the nitrogen atom (SNE) in the oxazolo moiety of the benzoxazole ring is related to the activity. The results obtained from the theoretical calculations and the observed MIC values show that 2-(3-pyridyl)- and 2-phenylbenzoxazole derivatives exhibit bio-isosteric effects for antimicrobial activity. Additionally, substituents at position 5 on the fused heterocyclic system contribute to the activity constructively or destructively depending on the type of microorganism screened.
Farmaco | 2002
Özlem Temiz Arpaci; Esin Şener; Ismail Yalcin; Nurten Altanlar
The synthesis and microbiological activity of a new series of N-[2-(p-substitutedphenyl)-5-benzoxazolyl]-cyclohexyl carboxamide, -cyclohexyl acetamide and -cyclohexyl propionamide derivatives (4-11) is described. The in vitro microbiological activity of the compounds was determined against gram-positive, gram-negative bacteria and the yeast Candida albicans in comparison with standard drugs. Microbiological results indicated that the synthesized compounds possessed a broad spectrum of activity against the tested microorganisms.
Ankara Universitesi Eczacilik Fakultesi Dergisi | 1991
Özlem Temiz; Esin Şener
Bu derlemede, sentetik veya semisentetik olarak hazırlanan benzoksazol, benzimidazol, benzotiyazol ve oksazolo (4,5-b) piridin türevlerinin antibakteıiyel ve antifungal etkilen araştırılmıştır. İncelenen bileşiklerin, MİK değerleri 6.25-200 g/ ml arasında değişmektedir. Benzoksazol ve analoglarında 2. konumdan sübstitüsyonun etki şeklini yönlendiril ken, 5. konumdan sübstitüsyonun etki şiddeti üzerinde rolü olduğu görülmüştür. Bileşiklerin kendi aralarında ve diğer standart antibiyotiklerle etki kıyaslamaları ele alınarak bir kısmının test edilen antibiyotiklerle eşit, bazen de daha etkili oldukları bulunmuştur.